Does microperimetry have a prognostic value in central serous chorioretinopathy?

Retina

Volumn 34, Issue 4, 2014, Pages 713-718

  Roisman, Luiz ^a   Ribeiro, João C ^a   Fechine, Francisco V ^b   Lavinsky, Daniel ^a   Moraes, Nilva ^a   Campos, Mauro ^a   Farah, Michel E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MACULAR THICKNESS; MALE; MICROPERIMETRY; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIMETRY; PREDICTIVE VALUE; PROGNOSIS; SLIT LAMP; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

ACUTE DISEASE; ADULT; CENTRAL SEROUS CHORIORETINOPATHY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RETINA; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 84897573384     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182a323fe     Document Type: Article

References (16)

1. Wang M, Munch IC, Hasler PW, et al. Central serous chorior-etinopathy Acta Ophthalmol 2008;86:126-145.
2. Chan WM, Lam DS, Lai TY, et al. Treatment of choroidal neovascularization in central serous chorioretinopathy by pho-todynamic therapy with verteporfin. Am J Ophthalmol 2003; 136:836-845.
3. Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous cho-rioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013;41:201-214.
4. Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 2002;133: 787-793.
5. Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013;58:103-126.
6. Iida T, Hagimura N, Sato T, Kishi S. Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 2000;129:16-20.
7. Burumcek E, Mudun A, Karacorlu S, Arslan MO. Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 1997;104: 616-622.
8. Ojima Y, Tsujikawa A, Hangai M, et al. Retinal sensitivity measured with micro perimeter 1 after resolution of central serous chorioretinopathy. Am J Ophthalmol 2008;146:77-84.
9. Springer C, Volcker HE, Rohrschneider K. Central serous chorioretinopathy-retinal function and morphology: microperim-etry and optical coherence tomography [in German]. Ophthalmo-loge 2006; 103: 791-797.
10. Ozdemir H, Karacorlu SA, Senturk F, et al. Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy. Eye (Lond) 2008;22:204-208.
11. Fok AC, Chan PP, Lam DS, Lai TY. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res 2011;46: 160-163.
12. Aggio FB, Roisman L, Melo GB, et al. Clinical factors related to visual outcome in central serous chorioretinopathy. Retina 2010;30:1128-1134.
13. Roisman L, Lavinsky D, Magalhaes F, et al. Fundus autofluor-escence and spectral domain OCT in central serous choriore-tinopathy. J Ophthalmol 2011;2011:706849.
14. Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorior-etinopathy: an update on pathogenesis and treatment. Eye (Lond) 2010;24:1743-1756.
15. Fujita K, Shinoda K, Imamura Y, et al. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous cho-rioretinopathy. Am J Ophthalmol 2012;154:579-585.
16. Oh J, Kim SW, Kwon SS, et al. Correlation of fundus auto-fluorescence gray values with vision and microperimetry in resolved central serous chorioretinopathy. Invest Ophthalmol Vis Sci 2012;53:179-184.